The incidence of central nervous system cancer in the US remains largely unchanged from 1990 to 2021, while disability ...
About 170,000 women in the United States are living with metastatic breast cancer—or cancer that has spread to other ...
In just the past 8 years since we launched this report, the 5-year survival rate has gone from 18% to nearly 30%,” said Harold Wimmer, President and CEO of the American Lung Association. In the US, ...
Tobacco remains the leading preventable cause of cancer death in the U.S., despite a dramatic decline in smoking, a new ...
A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, lowering the risk of death after eight years by 40.3%. What's more, the drug ...
A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...
2don MSN
This “evolutionary” trial will use tumor biopsies, blood samples, high-resolution imaging, and medical records to monitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback